My NCBI | Sign In
RSS Settings
  • Search: mccrudden k[Author] OR mccrudden k[Author]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Giant pulmonary sequestration: the rare case requiring the EXIT procedure with resection and ECMO.

    Mychaliska GB, Bryner BS, Nugent C, Barks J, Hirschl RB, McCrudden K, Chames M, Gomez-Fifer C, Servin MN, Chiravuri SD.

    Fetal Diagn Ther. 2009;25(1):163-6. Epub 2009 Mar 17.PMID: 19293587 [PubMed - indexed for MEDLINE]Related articles

    2.

    Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.

    Kadenhe-Chiweshe A, Papa J, McCrudden KW, Frischer J, Bae JO, Huang J, Fisher J, Lefkowitch JH, Feirt N, Rudge J, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ.

    Mol Cancer Res. 2008 Jan;6(1):1-9.PMID: 18234958 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cost considerations and applicant characteristics for the Pediatric Surgery Match.

    Little DC, Yoder SM, Grikscheit TC, Jackson CC, Fuchs JR, McCrudden KW, Holcomb GW 3rd.

    J Pediatr Surg. 2005 Jan;40(1):69-73; discussion 73-4.PMID: 15868561 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.

    Frischer JS, Huang J, Serur A, Kadenhe-Chiweshe A, McCrudden KW, O'Toole K, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ.

    Int J Oncol. 2004 Sep;25(3):549-53.PMID: 15289855 [PubMed - indexed for MEDLINE]Related articles

    5.

    Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis.

    Huang J, Soffer SZ, Kim ES, McCrudden KW, Huang J, New T, Manley CA, Middlesworth W, O'Toole K, Yamashiro DJ, Kandel JJ.

    Mol Cancer Res. 2004 Jan;2(1):36-42.PMID: 14757844 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor.

    Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, O'toole K, Yamashiro DJ, Kandel JJ.

    J Pediatr Surg. 2003 Nov;38(11):1569-73.PMID: 14614702 [PubMed - indexed for MEDLINE]Related articles

    7.

    Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma.

    Kaicker S, McCrudden KW, Beck L, New T, Huang J, Frischer JS, Serur A, Kadenhe-Chiweshe A, Yokoi A, Kandel JJ, Yamashiro DJ.

    Int J Oncol. 2003 Dec;23(6):1651-5.PMID: 14612937 [PubMed - indexed for MEDLINE]Related articles

    8.

    Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor.

    Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, O'Toole K, Yamashiro DJ, Kandel JJ.

    Oncol Rep. 2003 Sep-Oct;10(5):1271-4.PMID: 12883692 [PubMed - indexed for MEDLINE]Related articles

    9.

    Regression of established tumors and metastases by potent vascular endothelial growth factor blockade.

    Huang J, Frischer JS, Serur A, Kadenhe A, Yokoi A, McCrudden KW, New T, O'Toole K, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ.

    Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7785-90. Epub 2003 Jun 12.PMID: 12805568 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.

    McCrudden KW, Hopkins B, Frischer J, Novikov A, Huang J, Kadenhe A, New T, Yokoi A, Yamashiro DJ, Kandel JJ, Middlesworth W.

    J Pediatr Surg. 2003 Mar;38(3):308-14; discussion 308-14.PMID: 12632340 [PubMed - indexed for MEDLINE]Related articles

    11.

    Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma.

    Kim ES, Serur A, Huang J, Manley CA, McCrudden KW, Frischer JS, Soffer SZ, Ring L, New T, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ.

    Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11399-404. Epub 2002 Aug 12.PMID: 12177446 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Topotecan is anti-angiogenic in experimental hepatoblastoma.

    McCrudden KW, Yokoi A, Thosani A, Soffer SZ, Kim ES, Huang J, Manley C, O'toole K, Yamashiro DJ, Kandel JJ, Middlesworth W.

    J Pediatr Surg. 2002 Jun;37(6):857-61.PMID: 12037749 [PubMed - indexed for MEDLINE]Related articles

    13.

    Resistance of a VEGF-producing tumor to anti-VEGF antibody: unimpeded growth of human rhabdoid tumor xenografts.

    Soffer SZ, Kim E, Huang J, McCrudden K, Yokoi A, Moore JT, Manley C, O'Toole K, Middlesworth W, Stolar C, Yamashiro DJ, Kandel JJ.

    J Pediatr Surg. 2002 Mar;37(3):528-32.PMID: 11877682 [PubMed - indexed for MEDLINE]Related articles

    14.

    p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease.

    Huang J, Soffer SZ, Kim ES, Yokoi A, Moore JT, McCrudden KW, Manley C, Middlesworth W, O'Toole K, Stolar C, Yamashiro DJ, Kandel JJ.

    J Pediatr Surg. 2002 Mar;37(3):523-7.PMID: 11877681 [PubMed - indexed for MEDLINE]Related articles

    15.

    Distinct response of experimental neuroblastoma to combination antiangiogenic strategies.

    Kim ES, Soffer SZ, Huang J, McCrudden KW, Yokoi A, Manley CA, Middlesworth W, Kandel JJ, Yamashiro DJ.

    J Pediatr Surg. 2002 Mar;37(3):518-22.PMID: 11877680 [PubMed - indexed for MEDLINE]Related articles

    16.

    Synthesis of (R,S)-10-methyloctadecanoic acid (tuberculostearic acid) and key chiral 2-methyl branched intermediates.

    Wallace PA, Minnikin DE, McCrudden K, Pizzarello A.

    Chem Phys Lipids. 1994 May 23;71(2):145-62.PMID: 8076401 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity